Search by Drug Name or NDC

    NDC 66869-0404-07 Livalo 4.18 mg/1 Details

    Livalo 4.18 mg/1

    Livalo is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Kowa Pharmaceuticals America, Inc.. The primary component is PITAVASTATIN CALCIUM.

    Product Information

    NDC 66869-0404
    Product ID 66869-404_1783ecd3-0116-4ad8-9a43-25d5b2dc62e6
    Associated GPIs 39400058100341
    GCN Sequence Number 066351
    GCN Sequence Number Description pitavastatin calcium TABLET 4 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 28595
    HICL Sequence Number 036983
    HICL Sequence Number Description PITAVASTATIN CALCIUM
    Brand/Generic Brand
    Proprietary Name Livalo
    Proprietary Name Suffix n/a
    Non-Proprietary Name pitavastatin calcium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 4.18
    Active Ingredient Units mg/1
    Substance Name PITAVASTATIN CALCIUM
    Labeler Name Kowa Pharmaceuticals America, Inc.
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022363
    Listing Certified Through 2024-12-31

    Package

    NDC 66869-0404-07 (66869040407)

    NDC Package Code 66869-404-07
    Billing NDC 66869040407
    Package 7 TABLET, FILM COATED in 1 CARTON (66869-404-07)
    Marketing Start Date 2019-05-16
    NDC Exclude Flag N
    Pricing Information N/A